Treatment of thrombosed hemodialysis access grafts: Arrow-Trerotola percutaneous thrombolytic device versus pulse-spray thrombolysis. Arrow-Trerotola Percutaneous Thrombolytic Device Clinical Trial.

Trerotola, Scott O.; Vesely, Thomas M.; Lund, Gunnar B.; Soulen, Michael C.; Ehrman, Karen O.; Cardella, John F.

doi:10.1148/radiology.206.2.9457193

Cited by 148 publications

(75 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The patency rates 6 and 12 months after thrombolysis were 62 -80 % and 57 -69 %, respectively. Trerotola and colleagues demonstrated a 95 % primary success rate with a patency rate after 3 months of 39 % as a result of the use of PTD [84]. Compared to different mechanical thrombolysis instruments, Smits et al concluded that the treatment of the underlying stenosis was the only relevant factor for the treatment success of a thrombosed dialysis graft [85].…”

Section: Insufficient Dialysis Graftmentioning

confidence: 99%

Diagnosis and Treatment of Insufficient Dialysis Vascular Access

Kamper

Faizy²,

Haage³

2015

Fortschr Röntgenstr

View full text Add to dashboard Cite

A wide variety of diagnostic and minimally invasive modalities is currently available to radiologists for providing sufficient medical care for dialysis patients. In addition to clinical examination, ultrasound is the first line imaging method in suspected dialysis vascular access dysfunction. The percutaneous approach is the primarily recommended therapeutic option in many cases. This article reviews the current diagnostic and therapeutic methods in dialysis vascular access insufficiency. Key Points: ??Vascular access dysfunction is often elicited by stenosed vessels, which are regularly associated with concomitant thrombosis. ??Stenoses are commonly observed in the anastomosis, vascular access vein and also in the central venous system. ??Beside the clinical examination, sonography is the diagnostic method of first choice. ??Percutaneous balloon dilatation frequently is the first treatment option. Citation Format: ??Kamper L, Faizy TD, Haage P. Diagnosis and Treatment of Insufficient Dialysis Vascular Access. Fortschr R?ntgenstr 2015; 187: 360???371

show abstract

Section: Insufficient Dialysis Graftmentioning

confidence: 99%

Diagnosis and Treatment of Insufficient Dialysis Vascular Access

Kamper

Faizy²,

Haage³

2015

Fortschr Röntgenstr

View full text Add to dashboard Cite

show abstract

“…Subsequently, other publications demonstrated equivalent efficacy of other devices when compared to thrombolytic therapy [5][6][7].…”

Section: Introductionmentioning

confidence: 98%

“…Accepted treatments for acutely occluded access grafts include surgery and thrombolytic therapy/angioplasty [3]. Several mechanical thrombectomy devices have been developed recently in efforts to lessen the invasiveness and cost of surgery and decrease complications related to thrombolytic therapy [4][5][6][7]. One of the first mechanical thrombectomy devices to be developed, and the first to be approved for the US market, was the Amplatz thrombectomy device (ATD); however, the final results in the trial comparing the ATD with surgical thromboembolectomy (ST) to declot occluded DAG had yet to be published.…”

Section: Introductionmentioning

confidence: 99%

Thrombosed dialysis access grafts: randomized comparison of the Amplatz thrombectomy device and surgical thromboembolectomy

et al. 2004

View full text Add to dashboard Cite

We report the final results of the trial comparing the Amplatz thrombectomy device (ATD) with surgical thromboembolectomy (ST) to declot thrombosed dialysis access grafts (DAG). The study population consisted of 174 DAG, 109 of which were randomized to mechanical thrombectomy using the ATD and 65 of which were randomized to conventional surgical thromboembolectomy. Forty grafts were re-enrolled in the trial when they failed beyond the 90 days follow-up after the initial treatment. Thirty-one were re-enrolled for mechanical thrombectomy and nine were re-enrolled for surgical thrombectomy, resulting in a total of 140 ATD procedures and 74 surgical thromboembolectomy. Immediate thrombectomy success was defined as greater than 90% thrombus removal followed by the ability to dialyze after treatment, and analysis of long term success based on graft patency at 30 and 90 days, with successful dialysis. Immediate thrombectomy success with the ATD procedure was achieved in 79.2% and with ST in 73.4%. Patency of the graft, with successful dialysis, at 30 days with the ATD procedure was 79.2% and with ST was 73.4%. Patency of the graft, with successful dialysis, at 90 days with the ATD procedure was 75.2% and with ST was 67.8%. The data collected in this study provided a prospective comparison of mechanical thrombectomy with the ATD and ST performance in thrombosed DAG. The results of the performance of both methods were comparable. No statistically significant differences were seen.

show abstract

“…A variety of methods, including pulsespray pharmacomechanical thrombolysis, balloon-assisted thrombectomy, and several mechanical thrombectomy devices have been developed for the treatment of thrombosed hemodialysis grafts (3)(4)(5)(6)(7)(8). The dual access approach has been the most adopted method for performing percutaneous thrombectomy in loop-configured grafts.…”

Section: Discussionmentioning

confidence: 99%

Fogarty balloon application technique in dislodging residual thrombus at the single sheath entry point at the apex of thrombosed loop grafts

Goo

Yang²,

Kim³

et al. 2012

Diagn Interv Radiol

View full text Add to dashboard Cite

Treatment of thrombosed hemodialysis access grafts: Arrow-Trerotola percutaneous thrombolytic device versus pulse-spray thrombolysis. Arrow-Trerotola Percutaneous Thrombolytic Device Clinical Trial.

Abstract: The PTD is safe and effective for treating thrombosed hemodialysis access grafts. The technical and long-term success rates are similar to those of PSPMT; procedure times are shorter.

Cited by 148 publications

References 0 publications

Diagnosis and Treatment of Insufficient Dialysis Vascular Access

Diagnosis and Treatment of Insufficient Dialysis Vascular Access

Thrombosed dialysis access grafts: randomized comparison of the Amplatz thrombectomy device and surgical thromboembolectomy

Fogarty balloon application technique in dislodging residual thrombus at the single sheath entry point at the apex of thrombosed loop grafts

Contact Info

Product

Resources

About